Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2023-05-04 Regulatory Filings
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Collegium Pharmaceutical, Inc. It announces the issuance of a press release with financial results for the quarter ended March 31, 2023, and an earnings presentation. The document itself does not contain the financial results or detailed financial statements but rather furnishes these materials as exhibits. The length is 3739 characters, which is relatively short and consistent with an announcement rather than a full report. The key phrases include 'issued a press release announcing its financial results' and 'released an earnings presentation,' both attached as exhibits. According to the 'Menu vs Meal' rule, this is an announcement of earnings results and presentation, not the earnings release itself. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the release of financial results and presentation but does not contain the actual financial data or detailed analysis itself.
2023-05-04 English
ARS
Annual Report
2023-04-11 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-11 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-03-17 English
Regulatory Filings 2023
Regulatory Filings
2023-03-15 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-03-03 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.